# Dispatch Bio

**Canonical:** https://apis.io/providers/dispatch-bio/  
**Website:** https://dispatchbio.com  
**APIs profiled:** 0

Dispatch Bio is a biotech company focused on engineering a groundbreaking immunotherapy platform, Flare, to treat solid tumors. Founded in 2022 as a Penn spin‑out, the firm aims to overcome targeting and resistance challenges in cancer treatment, advancing its pipeline through pre‑clinical and early clinical studies. The company is backed by investors including Bristol Myers Squibb and seeks to create universal cancer therapies.

## Kin Score — 10.5 / 100 (minimal)

Scored 2026-10-23 under rubric 0.25.0.

| Facet | Score |
|---|---|
| Discoverability | 44.6 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 23.8 |
| Access Clarity | 10.5 |

Regulatory layer — **Horizontal (data, software, accessibility, platform)**: 9.8 (matched via fallback).

## Agent readiness — 3.1 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | documented |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |
| Pagination Ratio | na |
| Operation Distinctiveness | na |

## Security (1)

- **Dispatch Bio Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Biotechnology, Immunotherapy, Cancer, Platform, Startups

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/dispatch-bio/). Scores are computed from the provider's own public artifacts under a published rubric.